Innovative strides in medical-grade TPUs: ICP DAS-BMP to introduce groundbreaking solutions at CMEF and Medtec Japan

March 27, 2024 12:20 PM AEDT | By Cision
 Innovative strides in medical-grade TPUs: ICP DAS-BMP to introduce groundbreaking solutions at CMEF and Medtec Japan
Image source: Kalkine Media

HSINCHU, March 27, 2024 /PRNewswire/ -- ICP DAS-BMP (Biomedical Polymers), Asia's leading medical TPU (thermoplastic polyurethane) manufacturer and supplier, will exhibit at the International Component Manufacturing and Design Show (ICMD, part of CMEF) and Medtec Japan in April 2024. The company will showcase several series of medical-grade TPU pellets: Arothane™ (ARP series), Alithane™ (ALP series), and Durathane™ (ALC and ARC series).

Innovative strides in medical-grade TPUs ICP DAS-BMP to introduce groundbreaking solutions at CMEF and Medtec Japan
Innovative strides in medical-grade TPUs ICP DAS-BMP to introduce groundbreaking solutions at CMEF and Medtec Japan

At the exhibitions, ICP DAS-BMP will present the new Arothane™ ARP-W-G, a medical-grade aromatic polyether-based TPU loaded with 40-60% Tungsten as a radiopacifier. It demonstrates outstanding radiopacity compared to Barium Sulfate, making it particularly suitable for small-dimension or thin-walled devices. The ARP-W-G series is recognized for its small particle size, high fluidity, and excellent dispersion. It is highly recommended for use as guidewire coating material.

Engineering Arothane™ TPU (EARP series) is another new product that industry experts should not miss at the exhibition. The EARP series is a medical-grade aromatic polyester-based rigid TPU. It is distinguished from other TPUs by its high glass transition temperature (Tg) and exceptional light transmission attributes.

Two other highlights are Arothane™ ARP-B20 (20% Barium Sulfate) and Durathane™ ALC-B40 (40% Barium Sulfate), both of which passed the 90-day implantation test in accordance with ISO 10993-6 standard.

Other noteworthy products to be showcased are ALC-B30 and ALP-W for extrusion-based catheter manufacturing.

ICP DAS-BMP experts developed TPU pellets with varying percentages of contrasting elements using the in situ polymerization method, ensuring high biocompatibility for all TPU series. Products made from contrast-filled TPUs provide superior visualization, making them an important component for the production of minimally invasive medical devices.

Meet the company's experts at:

  • CMEF (ICMD) from April 11 to 14, 2024, Hall 8.1, National Exhibition and Convention Center (Shanghai), Booth M44 and M46
  • Medtec Japan from April 17 to 19, 2024, Tokyo Big Sight, East Halls 2–3, Booth 2002

About ICP DAS - BMP

ICP DAS-BMP, a Taiwan-based TPU manufacturer and supplier certified with ISO 13485, operates specialized laboratories dedicated to quality management. Drawing upon three decades of industrial automation expertise from its parent company ICP DAS, ICP DAS-BMP has implemented smart factory practices to enhance product quality and expedite delivery times. Additionally, the company provides responsive after-sales support and offers flexible solutions for small order quantities.

For more information, please visit: https://bmp.icpdas.com/

For TPU products and inquiries, contact: [email protected]


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.